Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II multicenter study of ripasudil after needling following trabeculectomy
jRCTs061220032Phase 2Completed
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of glatiramer acetate and ripasudil in Glaucoma. Primary endpoint: Incidence of ocular and other adverse reactions. Started Aug 2022; status: completed.
02
Drugs
glatiramer acetateripasudil
03
Conditions
Glaucoma
Beyond the preview
Go deeper on jRCTs061220032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220032.